Search results
Showing results for
The University's fundraising campaign has reached the £2 billion mark in record time. The generosity of its donors is funding financial support for students, ambitious programmes of academic research and high-quality new buildings and facilities.
Design, validation, and functional impact of oligonucleotides for multigene silencing in Alzheimer's disease.
Journal article
Woffindale C. et al, (2026), Mol Ther Nucleic Acids, 37
Report of a one-day convening on regulatory science, practices, and innovative approaches to facilitate approval of novel combination vaccines.
Journal article
Hausdorff WP. et al, (2026), Vaccine, 75
Dosing practices of caffeine therapy for apnoea of prematurity: a retrospective single-centre observational study.
Journal article
Fatunla OAT. et al, (2026), BMJ Paediatr Open, 10
Structure-guided design of a PfCyRPA-based vaccine against blood-stage malaria.
Journal article
Alam N. et al, (2026), EMBO Mol Med
B and T cell responses to pre-erythrocytic R21/Matrix-M and blood-stage RH5.1/Matrix-M malaria vaccines in endemic settings
Journal article
Bundi CK. et al, (2026), Frontiers in Immunology, 17
CMV Preventive and Treatment Studies in Children Undergoing Haematopoietic Stem Cell Transplant: A Systematic Review.
Journal article
Fusani L. et al, (2026), Rev Med Virol, 36
Broad lessons from negative trials in rare diseases.
Journal article
Servais L. and Oskoui M., (2026), Lancet Neurol, 25, 215 - 217
The Epidemiology and Clinical Burden of Human Adenovirus Respiratory Infections Among Hospitalized Children Under 5 Years in Jordan.
Journal article
Abu-Helalah M. et al, (2026), Pediatr Infect Dis J, 45, 229 - 235
Securing the future of immunisation: ESCMID’s vision
Journal article
Ramasamy MN. et al, (2026), CMI Communications, 3, 105167 - 105167
Maternal perspectives on the RSV vaccine (Abrysvo): a thematic analysis of survey findings from the first season of implementation in England and Scotland.
Journal article
O'Hagan S. et al, (2026), Arch Dis Child
Pooled analysis of PCV13 efficacy from controlled human infection trials in Malawi and the UK.
Journal article
Kudowa E. et al, (2026), NPJ Vaccines
Safety and Efficacy of Intraventricular Antibiotics for Central Nervous System Infections in Children: A Single-center Observational Study.
Journal article
Almarzooqi M. et al, (2026), Pediatr Infect Dis J
An Adenoviral Vectored Vaccine Protects Mice Against Aerosol Challenge with Yersinia pestis.
Journal article
Dold C. et al, (2026), Mol Ther
Normative growth trajectories of fetal brain regions validated by satisfactory maturation of neurodevelopmental domains at 2 years of age.
Journal article
Wyburd MK. et al, (2026), Nat Commun
Enhanced muscle uptake of chemically optimized miR-23b antisense oligonucleotides as lead compounds for myotonic dystrophy type 1.
Journal article
González-Martínez I. et al, (2026), Am J Hum Genet
Predicting Salmonella Typhi incidence using prevalence metrics from sentinel studies of community-onset bloodstream infections
Preprint
Hagedoorn N. et al, (2026)
Structures of proteinase 3 and the CD177 receptor complex reveal a major autoantibody epitope.
Journal article
Zheng-Gérard C. et al, (2026), EMBO Rep
Controlled human pneumococcal infection in the Netherlands: Colonisation, antibody responses and the impact of viral co-infection.
Journal article
van Beek LF. et al, (2026), J Infect, 92
Predicting Salmonella Typhi incidence using prevalence metrics from sentinel studies of community-onset bloodstream infections
Preprint
Hagedoorn NN. et al, (2026)